Description

Carbonic Acid, 5-[[(1,4-Dihydro-4-Oxo-3-Quinolinyl)Carbonyl]Amino]-4-(1,1-Dimethylethyl)-2-[2-[(Methoxycarbonyl)Oxy]-1,1-Dimethylethyl]Phenyl Methyl Ester is a sophisticated, high-purity synthetic intermediate designed for advanced pharmaceutical research and development. This compound is critical for medicinal chemists seeking to develop novel therapeutic agents, particularly within specific targeted pathways. Its complex molecular architecture makes it an essential building block for synthesizing potential drug candidates in oncology and other specialized therapeutic areas. Global B2B buyers rely on this material for its consistent quality and critical role in accelerating discovery pipelines.

Application

• Pharmaceutical Intermediate: Serves as a key precursor in the synthesis of novel active pharmaceutical ingredients (APIs), particularly for targeted cancer therapies.
• Medicinal Chemistry Research: Used as a specialized building block in structure-activity relationship (SAR) studies and lead optimization programs.
• Process Development: Employed in scaling up synthetic routes from laboratory to pilot plant scale for new drug candidates.
• Contract Research & Manufacturing (CRO/CMO): Supplied to service organizations supporting pharmaceutical companies in drug discovery and development.
• Reference Standard: Can be utilized as a high-purity analytical standard for method development and quality control in API manufacturing.
• Bioconjugation Studies: Potential use in developing antibody-drug conjugates (ADCs) or other targeted drug delivery systems due to its functional groups.

Basic Information

Product Name	Carbonic Acid, 5-[[(1,4-Dihydro-4-Oxo-3-Quinolinyl)Carbonyl]Amino]-4-(1,1-Dimethylethyl)-2-[2-[(Methoxycarbonyl)Oxy]-1,1-Dimethylethyl]Phenyl Methyl Ester
CAS No.	1246213-33-1
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	5-[[(1,4-Dihydro-4-oxo-3-quinolinyl)carbonyl]amino]-4-(tert-butyl)-2-[2-[(methoxycarbonyl)oxy]-1,1-dimethylethyl]phenyl methyl carbonate; Methyl 5-[(4-oxo-1,4-dihydroquinoline-3-carbonyl)amino]-4-tert-butyl-2-[2-(methoxycarbonyloxy)-2-methylpropyl]phenyl carbonate; Carbonic acid phenyl methyl ester derivative; Quinolinone-carbonyl amino phenyl methyl ester; 1246213-33-1; Advanced pharmaceutical intermediate 1246213-33-1
EINECS	Contact for details

Quality Control

Our Carbonic Acid, 5-[[(1,4-Dihydro-4-Oxo-3-Quinolinyl)Carbonyl]Amino]-4-(1,1-Dimethylethyl)-2-[2-[(Methoxycarbonyl)Oxy]-1,1-Dimethylethyl]Phenyl Methyl Ester is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity suitable for research and development. Each lot is supported by a comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles. While produced to meet exacting internal standards, specifications can be aligned with client requirements for critical parameters. We ensure full traceability and documentation in compliance with cGMP guidelines where applicable.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Keep the container tightly sealed to protect from moisture. For long-term storage, consider inert atmosphere conditions to ensure optimal stability.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 1.0%
Residual Solvents (GC)	Complies with ICH Q3C
Loss on Drying	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.